CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 58 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-10 | Hoang Peter L. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +41,200 | 41,200 | ||
| 2020-03-10 | Hoang Peter L. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +388,800 | 388,800 | ||
| 2020-03-10 | Vera Juan Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +26,600 | 26,600 | ||
| 2020-03-10 | Vera Juan Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +113,400 | 113,400 | ||
| 2020-03-10 | Szymanska Anna Vice President, Quality | Grant or award · Employee Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-03-10 | Szymanska Anna Vice President, Quality | Grant or award · Employee Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2020-03-10 | Loiacono Michael Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2020-03-10 | Loiacono Michael Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +119,100 | 119,100 | ||
| 2020-03-10 | Koneru Mythili Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +23,900 | 23,900 | ||
| 2020-03-10 | Koneru Mythili Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +116,100 | 116,100 | ||
| 2020-03-10 | Kim Anthony H. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2020-03-10 | Kim Anthony H. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +127,500 | 127,500 | ||
| 2020-03-10 | Hoang Tsvetelina P VP, Research and Development | Grant or award · Employee Stock Option (Right to Buy) | +14,600 | 14,600 | ||
| 2020-03-10 | Hoang Tsvetelina P VP, Research and Development | Grant or award · Employee Stock Option (Right to Buy) | +25,400 | 25,400 | ||
| 2020-03-10 | Garrett Gerald Vice President, Clinical Ops. | Grant or award · Employee Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2020-03-10 | Garrett Gerald Vice President, Clinical Ops. | Grant or award · Employee Stock Option (Right to Buy) | +38,300 | 38,300 | ||
| 2020-03-10 | Agopyan Nadia VP, Regulatory Affairs | Grant or award · Employee Stock Option (Right to Buy) | +7,300 | 7,300 | ||
| 2020-03-10 | Agopyan Nadia VP, Regulatory Affairs | Grant or award · Employee Stock Option (Right to Buy) | +32,700 | 32,700 | ||
| 2020-02-18 | Eastern Capital LTD 10% owner | Option exercise | +416,667 | $1.20 | $500K | 4,050,001 |
| 2020-02-18 | Eastern Capital LTD 10% owner | Option exercise · Series A-1 Warrant | −416,667 | 0 |
Page 5 of 6 · 119 trades